4D pharma PLC Sponsored ADR LBPS

Market cap
$37.2M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '21 Jun '21 Feb '21 Dec '20 Older periods
P/E ratio
0.00 0.00 — 0.00

+8 more quarters

P/S ratio
697.71 1,323.42 — 0.00
P/FCF ratio
0.00 0.00 — 0.00
P/Operating CF
(51.89) (106.61) — (6.29)
P/B ratio
31.35 30.86 — 4.36
EV/Sales
692.37 1,302.08 — 0.00
EV/EBITDA
0.00 0.00 — 0.00
EV/FCF
(10.81) (23.58) — (3.57)
Current Ratio
5.21 4.22 2.45 2.45
Net Debt/EBITDA
0.42 1.60 0.31 0.31
Debt/Equity
0.43 0.02 0.03 0.03
Earnings Yield
(12.34%) (7.29%) — (3.97%)
Free Cash Flow Yield
(9.18%) (4.17%) — (26.23%)
Free Cash Flow per Share
(0.10) (0.10) 0.00 (1.91)
Book value per Share
0.17 0.35 0.00 2.73
Free Cash Flow
(18.94) (16.21) (27.16) (27.29)
EV/EBIT
0.00 0.00 — 0.00
Other line items

Show all line items

Columns are period end dates